Trial Profile
Segmental Endoscopic Evaluation of Combined Oral and Topical Mesalazine (Pentasa) in patients with mild-to-moderate Ulcerative Colitis (UC)
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 13 Mar 2013 New trial record